Can computers help estimate the quality of cancer cell lines?
In a study funded by Open Targets, Lucia Trastulla and Francesco Iorio discuss the limitations of immortal cancer cell lines (CCLs) to investigate cancer biology in vitro and review the latest computational methods to evaluate the suitability of each CCL as experimental model on a case-by-case basis.
Immortal CCLs are widely adopted models to study cancer biology in vitro and are often used in high-throughput screening for drug discovery. However, misidentification, misclassification, and heterogeneity, as well as usage out of the original in vivo tumour context, not always make CCLs appropriate to translate findings from the bench to the bedside.
Lucia Trastulla and Francesco Iorio at the HT Computational Biology Research Centre, in collaboration with colleagues from the Cancer Dependency Map Project at the Broad Institute, USA, provide an overview of the main limitations of using CCLs as in vitro surrogates for in vivo cancer features and describe how computational methods can be leveraged to identify the best and most representative CCLs depending on the type of primary tumor under investigation. Furthermore, the researchers discuss how machine-learning-based approaches may help reduce discrepancies arising from multi-omics analyses, transfer CCL-based findings to more complex model systems and develop approaches for the realization of personalised medicine.
The review is now published in Molecular Systems Biology.
DOI 10.15252/msb.202211017
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.